Bumetanide for neonatal seizures: Based on evidence or enthusiasm?

Epilepsia

Volumn 50, Issue 5, 2009, Pages 1292-1293

  Vanhatalo, Sampsa ^a   Hellström Westas, Lena ^b   De Vries, Linda S ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BUMETANIDE; KAINIC ACID; MAGNESIUM; PHENOBARBITAL;

BRAIN REGION; CLINICAL FEATURE; DISEASE ACTIVITY; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; NEWBORN PERIOD; NONHUMAN; NOTE; PRIORITY JOURNAL; SEIZURE;

BUMETANIDE; EVIDENCE-BASED MEDICINE; HUMANS; INFANT; INFANT, NEWBORN; SEIZURES; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 65549092315     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01894.x     Document Type: Note

References (14)

1. Booth D, Evans DJ 2004) Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev 4 : CD004218.
2. Dreier JP, Zhang CL, Heinemann U 1998) Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development. Acta Neurol Scand 98 : 154 160. (Pubitemid 28435307)
3. Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE, Staley KJ 2005) NKCC1 transporter facilitates seizures in the developing brain. Nat Med 11 : 1205 1213. (Pubitemid 43093668)
4. Dzhala VI, Brumback AC, Staley KJ 2008) Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 63 : 222 235.
5. Haglund MM, Hochman DW 2005) Furosemide and mannitol suppression of epileptic activity in the human brain. J Neurophysiol 94 : 907 918. (Pubitemid 41061331)
6. Hochman DW, Baraban SC, Owens JW, Schwartzkroin PA 1995) Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity. Science 270 : 99 102.
7. Huberfeld G, Wittner L, Clemenceau S, Baulac M, Kaila K, Miles R, Rivera C 2007) Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J Neurosci 27 : 9866 9873. (Pubitemid 47404011)
8. Kilb W, Sinning A, Luhmann HJ 2007) Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse. Neuropharmacology 53 : 524 533. (Pubitemid 47284187)
9. Owens DF, Kriegstein AR 2002) Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3 : 715 727. (Pubitemid 135706677)
10. Pallas SL 2001) Intrinsic and extrinsic factors that shape neocortical specification. Trends Neurosci 24 : 417 423. (Pubitemid 32938545)
11. Rheims S, Represa A, Ben-Ari Y, Zilberter Y 2008) Layer specific generation and propagation of seizures in slices of developing neocortex: role of excitatory GABAergic synapses. J Neurophysiol 100 : 620 628.
12. Silverstein FS, Jensen FE, Inder T, Hellstrom-Westas L, Hirtz D, Ferriero DM 2008) Improving the treatment of neonatal seizures: national institute of neurological disorders and stroke workshop report. J Pediatr 153 : 12 15.
13. Sipilä ST, Schuchmann S, Voipio J, Yamada J, Kaila K 2006) The cation-chloride cotransporter NKCC1 promotes sharp waves in the neonatal rat hippocampus. J Physiol 573 : 765 773. (Pubitemid 43852771)
14. - uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1. J Physiol 557 (Pt 3 829 841. (Pubitemid 38961620)